跳至主要内容
临床试验/CTIS2023-506202-40-01
CTIS2023-506202-40-01进行中(未招募)1 期

Effectiveness of methylphenidate in children and adolescents with KBG syndrome: An N-of-1 series - 113883

Stichting Radboud University Medical Center0 个研究点目标入组 15 人开始时间: 2024年3月26日最近更新:

试验速览

阶段
1 期
状态
进行中(未招募)
发起方
入组人数
15

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
0 至 64(—)
性别
All

入选标准

  • Age 6-20 years, Molecularly confirmed diagnosis of KBG syndrome (pathogenic ANKRD11 variant or a chromosome 16q24 deletion including ANKRD11), Attention deficit or ADHD-related symptoms or a formal ADHD diagnosis, with a significant impact on daily life, Presence of a subject’s caregiver or supervisor for proxy-reports

排除标准

  • Family history of acute cardiac death that warrants further cardiac investigation, Inability to understand or speak Dutch, Cardiovascular disease in medical history (severe hypertension, heart failure, arterial occlusive disease, potentially life-threatening arrythmias, angina pectoris, hemodynamically significant congenital heart defect, cardiomyopathy, myocardial infarction and channelopathy), Current or previous presence of hyperthyroidism, glaucoma or pheochromocytoma, Use of (psychotropic/stimulant) drugs which interact with methylphenidate, Schizophrenic or psychotic disorder in medical history, Unstable epilepsy (not controlled with medication), History of frequent drug and/or alcohol abuse, Excessive alcohol/drug use and/or intoxication with one or both during the study, Pregnant or lactating women

研究者

发起方
Stichting Radboud University Medical Center

相似试验